Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant - Takashita, Emi; Kinoshita, Noriko; Yamayoshi, Seiya; Sakai-Tagawa, Yuko; Fujisaki, Seiichiro; Ito, Mutsumi; Iwatsuki-Horimoto, Kiyoko; Chiba, Shiho; Halfmann, Peter; Nagai, Hiroyuki; Saito, Makoto; Adachi, Eisuke; et al. (The New England journal of medicine, 2022)
Keywords: Antibodies, Monoclonal - pharmacology; Antibodies, Monoclonal - therapeutic use; Antiviral activity; Antiviral agents; Antiviral Agents - pharmacology; Antiviral Agents - therapeutic use; Coronavirus; Coronaviruses; Correspondence; COVID-19; COVID-19 Drug Treatment; DNA-directed RNA polymerase; Drugs; Enzyme-Linked Immunosorbent Assay; FDA approval; Infectious Disease; Infectious diseases; Influenza; Monoclonal antibodies; Mutation; Neutralization Tests; Pathogenesis; Proteinase inhibitors; Proteins; R&D; Research & development; RNA polymerase; SARS-CoV-2 - drug effects; SARS-CoV-2 - genetics; Severe acute respiratory syndrome coronavirus 2; United States--US; Japan